Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2018 Jan 18;951:70-81. doi: 10.1124/mol.118.113464.
Show Gene links
Show Anatomy links
Analysis of GABAA Receptor Activation by Combinations of Agonists Acting at the Same or Distinct Binding Sites.
Shin DJ, Germann AL, Covey DF, Steinbach JH, Akk G.
???displayArticle.abstract???
Under both physiologic and clinical conditions GABAA receptors are exposed to multiple agonists, including the transmitter GABA, endogenous or exogenous neuroactive steroids, and various GABAergic anesthetic and sedative drugs. The functional output of the receptor reflects the interplay among all active agents. We have investigated the activation of the concatemeric α1β2γ2L GABAA receptor by combinations of agonists. Simulations of receptor activity using the coagonist concerted transition model demonstrate that the response amplitude in the presence of agonist combinations is highly dependent on whether the paired agonists interact with the same or distinct sites. The experimental data for receptor activation by agonist combinations were in agreement with the established views of the overlap of binding sites for several pairs of orthosteric (GABA, β-alanine, and piperidine-4-sulfonic acid) and/or allosteric agents (propofol, pentobarbital, and several neuroactive steroids). Conversely, the degree of potentiation when two GABAergic agents are coapplied can be used to determine whether the compounds act by binding to the same or distinct sites. We show that common interaction sites mediate the actions of 5α- and 5β-reduced neuroactive steroids, and natural and enantiomeric steroids. Furthermore, the results indicate that the anesthetics propofol and pentobarbital interact with partially shared binding sites. We propose that the findings may be used to predict the efficacy of drug mixtures in combination therapy and thus have potential clinical relevance.
Akk,
GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity.
2018, Pubmed,
Xenbase
Akk,
GABA Type A Receptor Activation in the Allosteric Coagonist Model Framework: Relationship between EC50 and Basal Activity.
2018,
Pubmed
,
Xenbase Amin,
GABAA receptor needs two homologous domains of the beta-subunit for activation by GABA but not by pentobarbital.
1993,
Pubmed
,
Xenbase Baumann,
Individual properties of the two functional agonist sites in GABA(A) receptors.
2003,
Pubmed
,
Xenbase Bouzat,
New insights into the structural bases of activation of Cys-loop receptors.
2012,
Pubmed Bracamontes,
Occupation of either site for the neurosteroid allopregnanolone potentiates the opening of the GABAA receptor induced from either transmitter binding site.
2011,
Pubmed
,
Xenbase Bracamontes,
Steroid interaction with a single potentiating site is sufficient to modulate GABA-A receptor function.
2009,
Pubmed
,
Xenbase Cao,
Enhanced GABAergic actions resulting from the coapplication of the steroid 3α-hydroxy-5α-pregnane-11,20-dione (alfaxalone) with propofol or diazepam.
2018,
Pubmed
,
Xenbase Chang,
Allosteric activation mechanism of the alpha 1 beta 2 gamma 2 gamma-aminobutyric acid type A receptor revealed by mutation of the conserved M2 leucine.
1999,
Pubmed
,
Xenbase Chiara,
Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human α1β3γ2 γ-aminobutyric acid type A (GABAA) receptor.
2013,
Pubmed Chua,
GABAA Receptors and the Diversity in their Structure and Pharmacology.
2017,
Pubmed Eaton,
Multiple Non-Equivalent Interfaces Mediate Direct Activation of GABAA Receptors by Propofol.
2016,
Pubmed Eaton,
Mutational Analysis of the Putative High-Affinity Propofol Binding Site in Human β3 Homomeric GABAA Receptors.
2015,
Pubmed
,
Xenbase Forman,
Mutations in the GABAA receptor that mimic the allosteric ligand etomidate.
2012,
Pubmed
,
Xenbase Forman,
Monod-Wyman-Changeux allosteric mechanisms of action and the pharmacology of etomidate.
2012,
Pubmed Franks,
Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian γ-aminobutyric acid type A receptors.
2015,
Pubmed Germann,
Activation and modulation of recombinant glycine and GABAA receptors by 4-halogenated analogues of propofol.
2016,
Pubmed
,
Xenbase Hosie,
Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites.
2006,
Pubmed Jayakar,
Multiple propofol-binding sites in a γ-aminobutyric acid type A receptor (GABAAR) identified using a photoreactive propofol analog.
2014,
Pubmed Jones,
Defining affinity with the GABAA receptor.
1998,
Pubmed Krogsgaard-Larsen,
Piperidine-4-sulphonic acid, a new specific GABA agonist.
1980,
Pubmed Li,
The neurosteroid 5β-pregnan-3α-ol-20-one enhances actions of etomidate as a positive allosteric modulator of α1β2γ2L GABAA receptors.
2014,
Pubmed
,
Xenbase Li,
Natural and enantiomeric etiocholanolone interact with distinct sites on the rat alpha1beta2gamma2L GABAA receptor.
2007,
Pubmed Maldifassi,
Functional sites involved in modulation of the GABAA receptor channel by the intravenous anesthetics propofol, etomidate and pentobarbital.
2016,
Pubmed
,
Xenbase Miller,
Structural basis for GABAA receptor potentiation by neurosteroids.
2017,
Pubmed MONOD,
ON THE NATURE OF ALLOSTERIC TRANSITIONS: A PLAUSIBLE MODEL.
1965,
Pubmed Nilsson,
Neurosteroid analogues. 6. The synthesis and GABAA receptor pharmacology of enantiomers of dehydroepiandrosterone sulfate, pregnenolone sulfate, and (3alpha,5beta)-3-hydroxypregnan-20-one sulfate.
1998,
Pubmed Nourmahnad,
Tryptophan and Cysteine Mutations in M1 Helices of α1β3γ2L γ-Aminobutyric Acid Type A Receptors Indicate Distinct Intersubunit Sites for Four Intravenous Anesthetics and One Orphan Site.
2016,
Pubmed
,
Xenbase Olsen,
GABAA receptor: Positive and negative allosteric modulators.
2018,
Pubmed O'Shea,
Propofol increases agonist efficacy at the GABA(A) receptor.
2000,
Pubmed Ruesch,
An allosteric coagonist model for propofol effects on α1β2γ2L γ-aminobutyric acid type A receptors.
2012,
Pubmed
,
Xenbase Shin,
The Actions of Drug Combinations on the GABAA Receptor Manifest as Curvilinear Isoboles of Additivity.
2017,
Pubmed
,
Xenbase Shin,
Propofol Is an Allosteric Agonist with Multiple Binding Sites on Concatemeric Ternary GABAA Receptors.
2018,
Pubmed
,
Xenbase Sieghart,
Allosteric modulation of GABAA receptors via multiple drug-binding sites.
2015,
Pubmed Ziemba,
Correction for Inhibition Leads to an Allosteric Co-Agonist Model for Pentobarbital Modulation and Activation of α1β3γ2L GABAA Receptors.
2016,
Pubmed
,
Xenbase
